Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-CH3) (BSDBC-158)

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-EGFR and anti-ZnO antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can be used in immunoassay of Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors.

Datasheet INQUIRY

Specifications

Targets

EGFR & ZnO

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

Immunoassay

Related Disease

Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors

Targets

Target 1

EGFR

Gene ID

1956

UniProt ID

P00533

Alternative Names

EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog

Target 2

ZnO

Alternative Names

ZnO; Zinc oxide

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-CH3) (BSDBC-158). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-158)

Specifications

Targets

Customer Reviews and Q&As